Literature DB >> 21725863

Isolation rates of Brucella melitensis in an endemic area and implications for laboratory safety.

A A Shemesh1, P Yagupsky.   

Abstract

A retrospective study was conducted to assess the potential threat posed by processing blood cultures to clinical microbiology laboratory personnel working in an area endemic for Brucella melitensis in southern Israel. The computerized laboratory records for the 2002-2009 period were reviewed, and the proportion of aerobic vials from which Brucella organisms were isolated out of the total number of positive aerobic blood culture vials was determined. During the 8-year period, B. melitensis was isolated in 514 of 20,620 (2.5%) positive vials. Isolation rate increased at the end of the period reaching a peak of 5.3% in 2008. Between April 2008 and September 2009, the proportion of aerobic blood cultures from which B. melitensis was isolated was even higher than that positive for pneumococci (4.3% and 2.6%, respectively, P < 0.001). Although it has been recommended that processing of Brucella cultures should be confined to a Class II biologic safety cabinet, by the time the organism is identified, extensive manipulation of culture media has already been performed and inadvertent exposure of laboratory personnel may have already occurred. To reduce the risk of transmission, all positive blood culture vials in endemic areas should be processed in a safety cabinet.

Entities:  

Mesh:

Year:  2011        PMID: 21725863     DOI: 10.1007/s10096-011-1325-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

Review 1.  Detection of Brucellae in blood cultures.

Authors:  P Yagupsky
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 2.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

3.  Isolation, identification, and characterization in Israel of Brucella melitensis biovar 1 atypical strains susceptible to dyes and penicillin, indicating the evolution of a new variant.

Authors:  M Banai; I Mayer; A Cohen
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Past and present hazards of working with infectious agents.

Authors:  R M Pike
Journal:  Arch Pathol Lab Med       Date:  1978-07       Impact factor: 5.534

5.  Comparison of BACTEC 9240 Peds Plus medium and isolator 1.5 microbial tube for detection of Brucella melitensis from blood cultures.

Authors:  P Yagupsky; N Peled; J Press; O Abramson; M Abu-Rashid
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Analysis of risk factors for laboratory-acquired brucella infections.

Authors:  O Ergönül; A Celikbaş; D Tezeren; E Güvener; B Dokuzoğuz
Journal:  J Hosp Infect       Date:  2004-03       Impact factor: 3.926

7.  Laboratory-acquired brucellosis.

Authors:  Stephanie Noviello; Richard Gallo; Molly Kelly; Ronald J Limberger; Karen DeAngelis; Louise Cain; Barbara Wallace; Nellie Dumas
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 8.  Laboratory exposures to brucellae and implications for bioterrorism.

Authors:  Pablo Yagupsky; Ellen Jo Baron
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  8 in total
  5 in total

Review 1.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  The Bactec FX Blood Culture System Detects Brucella melitensis Bacteremia in Adult Patients within the Routine 1-Week Incubation Period.

Authors:  Moshe Sagi; Lior Nesher; Pablo Yagupsky
Journal:  J Clin Microbiol       Date:  2017-01-04       Impact factor: 5.948

3.  Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children.

Authors:  Eugene Leibovitz; Joseph Kapelushnik; Sabrin Alsanaa; Dov Tschernin; Ruslan Sergienko; Ron Leibovitz; Julia Mazar; Yariv Fruchtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-27       Impact factor: 3.267

4.  Early diagnosis and treatment of acute brucellosis knee arthritis complicated by acute osteomyelitis: two cases report.

Authors:  Jie Wang; Qiang Zhang
Journal:  BMC Infect Dis       Date:  2022-05-04       Impact factor: 3.667

5.  A health promotion perspective for the control and prevention of Brucellosis (Brucella melitensis); Israel as a case study.

Authors:  Orna Baron-Epel; Samira Obeid; Dorit Kababya; Shiran Bord; Vicki Myers
Journal:  PLoS Negl Trop Dis       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.